NCT00135057View on ClinicalTrials.gov

Insulin Glulisine in Adult Subjects With Type 2 Diabetes Receiving Insulin Glargine as Basal Insulin

PHASE3CompletedINTERVENTIONAL
Enrollment

281

Participants

Timeline

Start Date

April 30, 2004

Study Completion Date

August 31, 2005

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

insulin glulisine

DRUG

insulin glargine

Trial Locations (1)

08807

Sanofi-Aventis, Bridgewater

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY